Maximize the potential of your asset.
Our global medical team brings deep industry expertise, scientific rigor, and proven frameworks to support you in developing your asset.
We leverage our knowledge of clinical trials, RWD/RWE, EMR and claims data, HEOR, and country requirements to ensure every asset has a fit-for-purpose plan for success.
Through systematic scientific rigor and analysis using proven frameworks, we can help you develop a robust asset development plan by:
Get the latest insights and perspectives from our experts.
The evolution of Medical Affairs as a pivotal strategic leader at this year’s sold-out Medical Affairs Professional Society (MAPS).
US and EU regulatory agencies provided the client with new guidance on generating supportive evidence for the proposed launch indication and future.
Read how our client aims to locate organizations advancing AI algorithms for rare disease detection.
Putnam helped the client to support development of local medical launch readiness plans for a new vaccine.
Looking to get in touch with an expert or team member?
Tell us how we can help.
